Skip to content

Carestream Digital Radiography Long Length Imaging Software Data Collection Protocol

Carestream Digital Radiography Long Length Imaging Manual Stitch Editor Software Data Collection

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01592435
Acronym
LLI-MSE
Enrollment
76
Registered
2012-05-07
Start date
2011-04-30
Completion date
2012-12-31
Last updated
2017-04-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Spinal Injuries

Brief summary

The study objective is to acquire composite images generated by the Carestream Long Length Imaging (LLI) software and demonstrate that the images stitched using the Carestream LLI software and the images stitched using a approved predicate device are acceptable for clinical use.

Detailed description

The study consists of subject enrollment to collect images in a clinical setting, followed by a review of the stitched images by radiologists or qualified orthopedic surgeons to assess overall usability of the composite images. This study includes clinical data collection of individual (raw and processed) and composite DR images from a Carestream device using alpha rotation to acquire the images. There is no subject involvement other than obtaining informed consent in order to use patient images and Case Record Forms (CRF), including supporting radiology reports. This study has no effect on clinical treatment and no foreseen risks to enrolled subjects. The predicate software is currently in place at the sites. Carestream will harvest that data and reconstruct with investigational software offsite. A comparison reader study will be performed upon completion of data collection. Please note this study is considered to be observational because there were no imaging of subject using investigational device. Subjects requiring standard of care diagnostic images were exposed using the commercially available Cedara system. The images captured on the Cedara system were then re-processed using the Carestream investigational software. Subjects gave informed consent for Carestream to reprocess their image data. They did not require any additional imaging using the investigational device.

Interventions

None listed

Sponsors

Carestream Health, Inc.
Lead SponsorINDUSTRY

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
Yes

Inclusion criteria

* subject has provided informed consent * Male or Female who require Long Length Imaging

Exclusion criteria

* Not able or willing to provide Informed Consent, or consent is withdrawn * Not able to collect all required case information * Patients who are unable to stand * Images which are not clinically acceptable to the user * Images without a reference object such as a ruler in the image.

Design outcomes

Primary

MeasureTime frameDescription
Radlex Scale for Diagnostic Capability Ratings - Cedara Accustitch Software (Predicate)5 weeks after completion of data collection1-Non-diagnostic - Unacceptable for diagnostic purposes. 2-Limited - Acceptable, with some technical defect. 3-Diagnostic - Image quality that would be expected routinely when imaging cooperative patients. 4-Exemplary - Good, most adequate for diagnostic purposes.
Radlex Scale for Diagnostic Capability Ratings - Carestream DR LLI Software (Investigational)5 weeks after completion of data collection1-Non-diagnostic - Unacceptable for diagnostic purposes. 2-Limited - Acceptable, with some technical defect. 3-Diagnostic - Image quality that would be expected routinely when imaging cooperative patients. 4-Exemplary - Good, most adequate for diagnostic purposes.

Countries

United States

Participant flow

Participants by arm

ArmCount
Pred. & Invest.-All Study Participants
Cedera AccuStitch Software is standard of care software currently used at sites. Carestream DR LLI software is investigational software used for reconstruction
76
Total76

Baseline characteristics

CharacteristicPred. & Invest.-All Study Participants
Age, Categorical
<=18 years
19 Participants
Age, Categorical
>=65 years
0 Participants
Age, Categorical
Between 18 and 65 years
57 Participants
Sex: Female, Male
Female
44 Participants
Sex: Female, Male
Male
32 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
— / —— / —
other
Total, other adverse events
0 / 760 / 76
serious
Total, serious adverse events
0 / 760 / 76

Outcome results

Primary

Radlex Scale for Diagnostic Capability Ratings - Carestream DR LLI Software (Investigational)

1-Non-diagnostic - Unacceptable for diagnostic purposes. 2-Limited - Acceptable, with some technical defect. 3-Diagnostic - Image quality that would be expected routinely when imaging cooperative patients. 4-Exemplary - Good, most adequate for diagnostic purposes.

Time frame: 5 weeks after completion of data collection

ArmMeasureValue (MEAN)Dispersion
Predicate - Cedera AccuStitch SoftwareRadlex Scale for Diagnostic Capability Ratings - Carestream DR LLI Software (Investigational)3.16 units on a scaleStandard Error 0.07
p-value: 0t-test, 1 sided
Primary

Radlex Scale for Diagnostic Capability Ratings - Cedara Accustitch Software (Predicate)

1-Non-diagnostic - Unacceptable for diagnostic purposes. 2-Limited - Acceptable, with some technical defect. 3-Diagnostic - Image quality that would be expected routinely when imaging cooperative patients. 4-Exemplary - Good, most adequate for diagnostic purposes.

Time frame: 5 weeks after completion of data collection

ArmMeasureValue (MEAN)Dispersion
Predicate - Cedera AccuStitch SoftwareRadlex Scale for Diagnostic Capability Ratings - Cedara Accustitch Software (Predicate)3.01 units on a scaleStandard Error 0.04
p-value: 0.02t-test, 1 sided

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026